These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23253635)

  • 1. Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study.
    Cepeda MS; Fife D; Vo L; Mastrogiovanni G; Yuan Y
    J Pain; 2013 Feb; 14(2):158-64. PubMed ID: 23253635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.
    Cepeda MS; Fife D; Ma Q; Ryan PB
    J Pain; 2013 Oct; 14(10):1227-41. PubMed ID: 23850177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse.
    Cepeda MS; Fife D; Kihm MA; Mastrogiovanni G; Yuan Y
    Clin J Pain; 2014 Dec; 30(12):1051-6. PubMed ID: 24370606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid shopping behavior: how often, how soon, which drugs, and what payment method.
    Cepeda MS; Fife D; Chow W; Mastrogiovanni G; Henderson SC
    J Clin Pharmacol; 2013 Jan; 53(1):112-7. PubMed ID: 23400751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin).
    Chilcoat HD; Coplan PM; Harikrishnan V; Alexander L
    Drug Alcohol Depend; 2016 Aug; 165():221-8. PubMed ID: 27372220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US.
    Cepeda MS; Fife D; Chow W; Mastrogiovanni G; Henderson SC
    Drug Saf; 2012 Apr; 35(4):325-34. PubMed ID: 22339505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the abuse of tapentadol immediate release: the first 24 months.
    Dart RC; Cicero TJ; Surratt HL; Rosenblum A; Bartelson BB; Adams EH
    J Opioid Manag; 2012; 8(6):395-402. PubMed ID: 23264317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distance traveled and frequency of interstate opioid dispensing in opioid shoppers and nonshoppers.
    Cepeda MS; Fife D; Yuan Y; Mastrogiovanni G
    J Pain; 2013 Oct; 14(10):1158-61. PubMed ID: 23791042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: a randomized, phase IIIb study.
    Vorsanger GJ; Klopfer AM; Xiang J; Benson CJ; Moskovitz BL; Rosenthal NR
    J Opioid Manag; 2013; 9(4):281-90. PubMed ID: 24353022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries.
    Ponté C; Lepelley M; Boucherie Q; Mallaret M; Lapeyre Mestre M; Pradel V; Micallef J
    Drug Alcohol Depend; 2018 Jun; 187():88-94. PubMed ID: 29649695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doctor shopping reveals geographical variations in opioid abuse.
    Nordmann S; Pradel V; Lapeyre-Mestre M; Frauger E; Pauly V; Thirion X; Mallaret M; Jouanjus E; Micallef J
    Pain Physician; 2013 Jan; 16(1):89-100. PubMed ID: 23340537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.
    Etropolski M; Kelly K; Okamoto A; Rauschkolb C
    Adv Ther; 2011 May; 28(5):401-17. PubMed ID: 21494892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment.
    Butler SF; McNaughton EC; Black RA
    Pain Med; 2015 Jan; 16(1):119-30. PubMed ID: 25243972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of prescribers whose patients shop for opioids: results from a cohort study.
    Cepeda MS; Fife D; Berlin JA; Mastrogiovanni G; Yuan Y
    J Opioid Manag; 2012; 8(5):285-91. PubMed ID: 23247905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tapentadol extended release on productivity: results from an analysis combining evidence from multiple sources.
    Cepeda MS; Sutton A; Weinstein R; Kim M
    Clin J Pain; 2012 Jan; 28(1):8-13. PubMed ID: 21646907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
    Daniels S; Casson E; Stegmann JU; Oh C; Okamoto A; Rauschkolb C; Upmalis D
    Curr Med Res Opin; 2009 Jun; 25(6):1551-61. PubMed ID: 19445652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.
    Vosburg SK; Severtson SG; Dart RC; Cicero TJ; Kurtz SP; Parrino MW; Green JL
    J Pain; 2018 Apr; 19(4):439-453. PubMed ID: 29224919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency.
    Eichenbaum G; Göhler K; Etropolski M; Steigerwald I; Pergolizzi J; Kim M; Vorsanger G
    J Opioid Manag; 2015; 11(3):211-27. PubMed ID: 25985806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies.
    Merchant S; Provenzano D; Mody S; Ho KF; Etropolski M
    J Opioid Manag; 2013; 9(1):51-61. PubMed ID: 23709304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.